m-EASIX (better than EASIX) predicts severe CAR T-cell toxicities, worse overall survival, and discriminates cytokine release syndrome from sepsis Front Immunol
Allo-HCT with post-transplant cyclophosphamide in older adults: similar safety and a viable option compared to younger adults Front Immunol
One-year consolidation with Ponatinib 15 mg in chronic myeloid leukaemia on deep molecular response with Imatinib Ann Hematol
Prostate Cancer Incidence by Age and Clinicopathological Characteristics: A Population-Based Study in Girona, Spain, 2010 to 2021 CLIN GENITOURIN CANC
Red blood cell immunization as an independent predictor of survival in the myelodysplastic syndromes BRIT J HAEMATOL
Conjugation strategy shapes antitumor efficacy and enables dose-sparing in non-antibody protein nanoconjugates Mater Today Bio
EASIX, a new tool to predict response and refractoriness in immune-mediated thrombotic thrombocytopenic purpura Front Immunol
Breast cancer incidence, by stage at diagnosis, and mortality in 21 European countries in the era of mammography screening: an international population-based study LANCET REG HEALTH-EU
Polygenic risk for white matter hyperintensities is associated with early cerebrovascular events partly through hemodynamic measures in cognitively unimpaired middle-aged and older adults with low cardiovascular risk Front Neurol
HCT Pre-App Program: A Telemedicine-based Prehabilitation for Allogeneic Hematopoietic Cell Transplant candidates Blood Adv